Literature DB >> 4588852

Evaluation of aerosols of prostaglandins E1 and E2 as bronchodilators.

Y Kawakami, K Uchiyama, T Irie, M Murao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4588852     DOI： 10.1007/bf00562439

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  17 in total

1.  Distribution of prostaglandins in human tissues.

Authors:  S M Karim; M Sandler; E D Williams
Journal:  Br J Pharmacol Chemother       Date:  1967

2.  Mechanical factors in distribution of pulmonary ventilation.

Authors:  A B OTIS; C B MCKERROW; R A BARTLETT; J MEAD; M B MCILROY; N J SELVER-STONE; E P RADFORD
Journal:  J Appl Physiol       Date:  1956-01       Impact factor: 3.531

3.  Effects of prostaglandins on human bronchial muscle.

Authors:  W J Sweatman; H O Collier
Journal:  Nature       Date:  1968-01-06       Impact factor: 49.962

4.  Bronchodilator activity of aerosols of prostaglandins E1 and E2 in asthmatic subjects.

Authors:  M F Cuthbert
Journal:  Proc R Soc Med       Date:  1971-01

5.  Frequency dependence of compliance as a test for obstruction in the small airways.

Authors:  A J Woolcock; N J Vincent; P T Macklem
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

6.  Bronchodilator activity of an aerosol of prostaglandin E1 in experimental animals.

Authors:  B J Large; P F Leswell; D R Maxwell
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

7.  Cardiovascular effects of prostaglandin E1.

Authors:  J Nakano; J R McCurdy
Journal:  J Pharmacol Exp Ther       Date:  1967-06       Impact factor: 4.030

8.  The effects of posture, oxygen, isoproterenol and atropine on ventilation-perfusion relationships in the lung in asthma.

Authors:  G B Field
Journal:  Clin Sci       Date:  1967-04       Impact factor: 6.124

9.  Prostaglandins: their disappearance from and release into the circulation.

Authors:  S H Ferreira; J R Vane
Journal:  Nature       Date:  1967-12-02       Impact factor: 49.962

10.  A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.

Authors:  A B DUBOIS; S Y BOTELHO; J H COMROE
Journal:  J Clin Invest       Date:  1956-03       Impact factor: 14.808
View more
  13 in total

1.  The anti-inflammatory effects of PGE2 on human lung macrophages are mediated by the EP4 receptor.

Authors:  Sharonjit K Gill; Yiwen Yao; Linda J Kay; Martin A Bewley; Helen M Marriott; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2016-09-06       Impact factor: 8.739

2.  Bronchodilation induced by PGE2 is impaired in Group III pulmonary hypertension.

Authors:  Gulsev Ozen; Chabha Benyahia; Salma Mani; Kamel Boukais; Adam M Silverstein; Richard Bayles; Andrew C Nelsen; Yves Castier; Claire Danel; Hervé Mal; Lucie H Clapp; Dan Longrois; Xavier Norel
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

3.  Can GPCRs Be Targeted to Control Inflammation in Asthma?

Authors:  Pawan Sharma; Raymond B Penn
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.

Authors:  James V Michael; Adelina Gavrila; Ajay P Nayak; Tonio Pera; Jennifer R Liberato; Steven R Polischak; Sushrut D Shah; Deepak A Deshpande; Raymond B Penn
Journal:  FASEB J       Date:  2019-01-02       Impact factor: 5.191

5.  Prostanoids and the cough reflex.

Authors:  Sarah A Maher; Maria G Belvisi
Journal:  Lung       Date:  2009-10-15       Impact factor: 2.584

6.  Characteristics of prostaglandin induced cough in man.

Authors:  J F Costello; L S Dunlop; P J Gardiner
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

7.  Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy.

Authors:  Sarah A Maher; Mark A Birrell; Maria G Belvisi
Journal:  Am J Respir Crit Care Med       Date:  2009-09-03       Impact factor: 21.405

Review 8.  Targeting TRP channels for chronic cough: from bench to bedside.

Authors:  Sara J Bonvini; Mark A Birrell; Jaclyn A Smith; Maria G Belvisi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-10       Impact factor: 3.000

9.  EP4 receptor as a new target for bronchodilator therapy.

Authors:  James Buckley; Mark A Birrell; Sarah A Maher; Anthony T Nials; Deborah L Clarke; Maria G Belvisi
Journal:  Thorax       Date:  2011-05-23       Impact factor: 9.139

Review 10.  New targets for resolution of airway remodeling in obstructive lung diseases.

Authors:  Ajay P Nayak; Deepak A Deshpande; Raymond B Penn
Journal:  F1000Res       Date:  2018-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.